Matches in SemOpenAlex for { <https://semopenalex.org/work/W2273533722> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2273533722 endingPage "1388" @default.
- W2273533722 startingPage "1384" @default.
- W2273533722 abstract "OBJECTIVE To explore in vitro cytotoxicity and in vivo antitumor effect of semi-dynthesized alkannin derivatives of[3,11-bis(2-hydroxyethanesulfonyl)-6-isohexenylnaph-thazarin,SYUNZ-4].METHODS The cytotoxicity of SYUNZ-4 was assayed using MTT method.Efficiency was evaluated using IC50.In vivo antitumor effect was tested by models of transplanted tumor in mice and nude mice.RESULTS SYUNZ-4 presented strong cytotoxicities on 7 kinds of human cancer cell lines.The IC50 were 0.30~7.75 mg·L-1.The IC50 of SYUNZ-4 to 2 kinds of MDR cells (MCF-7/ADR and KBV200) were 1.96 and 7.78 mg·L-1.Under the doses of 2.0, 6.0 and 10.0 mg·kg-1, ip, q2d×10 d, the tumor inhibitory rates of SYUNZ-4 to against sarcoma S-180 and HepS in mice, were 31.5%~69.7% and 45.9%~67.5%,respectively (P0.01~0.001).Under the doses of 2.0, 6.0, 10.0 and 14.0 mg·kg-1, the tumor inhibitory rates on tumor ESC in mice were 30.2%~58.1% (P0.05~0.01).Under the doses of 6.0 and 10.0 mg·kg-1, ip, q3d×18 d, the tumor inhibitory rates of SYUNZ-4 to human lung adenocarcinoma cell (GLC-82) xenografts in nude mice were 48.4% and 61.7% (P0.01~0.001).Under the doses of 2.0, 6.0 and 10.0 mg·kg-1, the tumor inhibitory rates of SYUNZ-4 on human nasopharyngeal carcinoma (CNE2) xenografts in nude mice were 35.5%, 41.9% and 48.3%, respectively (P0.01~0.001).CONCLUSION SYUNZ-4 has strong cytotoxity and antitumor activity." @default.
- W2273533722 created "2016-06-24" @default.
- W2273533722 creator A5000168886 @default.
- W2273533722 creator A5002708015 @default.
- W2273533722 creator A5014160666 @default.
- W2273533722 creator A5026041577 @default.
- W2273533722 creator A5027750584 @default.
- W2273533722 creator A5029667848 @default.
- W2273533722 creator A5039439855 @default.
- W2273533722 creator A5047624707 @default.
- W2273533722 creator A5065823709 @default.
- W2273533722 creator A5080374885 @default.
- W2273533722 date "2007-09-01" @default.
- W2273533722 modified "2023-09-22" @default.
- W2273533722 title "Antitumor Effect of Alkannin Derivative,SYUNZ-4" @default.
- W2273533722 hasPublicationYear "2007" @default.
- W2273533722 type Work @default.
- W2273533722 sameAs 2273533722 @default.
- W2273533722 citedByCount "0" @default.
- W2273533722 crossrefType "journal-article" @default.
- W2273533722 hasAuthorship W2273533722A5000168886 @default.
- W2273533722 hasAuthorship W2273533722A5002708015 @default.
- W2273533722 hasAuthorship W2273533722A5014160666 @default.
- W2273533722 hasAuthorship W2273533722A5026041577 @default.
- W2273533722 hasAuthorship W2273533722A5027750584 @default.
- W2273533722 hasAuthorship W2273533722A5029667848 @default.
- W2273533722 hasAuthorship W2273533722A5039439855 @default.
- W2273533722 hasAuthorship W2273533722A5047624707 @default.
- W2273533722 hasAuthorship W2273533722A5065823709 @default.
- W2273533722 hasAuthorship W2273533722A5080374885 @default.
- W2273533722 hasConcept C109316439 @default.
- W2273533722 hasConcept C121608353 @default.
- W2273533722 hasConcept C126322002 @default.
- W2273533722 hasConcept C150903083 @default.
- W2273533722 hasConcept C185592680 @default.
- W2273533722 hasConcept C202751555 @default.
- W2273533722 hasConcept C207001950 @default.
- W2273533722 hasConcept C2777752497 @default.
- W2273533722 hasConcept C2780783641 @default.
- W2273533722 hasConcept C2781182431 @default.
- W2273533722 hasConcept C55493867 @default.
- W2273533722 hasConcept C71924100 @default.
- W2273533722 hasConcept C86803240 @default.
- W2273533722 hasConcept C98274493 @default.
- W2273533722 hasConceptScore W2273533722C109316439 @default.
- W2273533722 hasConceptScore W2273533722C121608353 @default.
- W2273533722 hasConceptScore W2273533722C126322002 @default.
- W2273533722 hasConceptScore W2273533722C150903083 @default.
- W2273533722 hasConceptScore W2273533722C185592680 @default.
- W2273533722 hasConceptScore W2273533722C202751555 @default.
- W2273533722 hasConceptScore W2273533722C207001950 @default.
- W2273533722 hasConceptScore W2273533722C2777752497 @default.
- W2273533722 hasConceptScore W2273533722C2780783641 @default.
- W2273533722 hasConceptScore W2273533722C2781182431 @default.
- W2273533722 hasConceptScore W2273533722C55493867 @default.
- W2273533722 hasConceptScore W2273533722C71924100 @default.
- W2273533722 hasConceptScore W2273533722C86803240 @default.
- W2273533722 hasConceptScore W2273533722C98274493 @default.
- W2273533722 hasIssue "18" @default.
- W2273533722 hasLocation W22735337221 @default.
- W2273533722 hasOpenAccess W2273533722 @default.
- W2273533722 hasPrimaryLocation W22735337221 @default.
- W2273533722 hasRelatedWork W1987952603 @default.
- W2273533722 hasRelatedWork W2059686754 @default.
- W2273533722 hasRelatedWork W2163613790 @default.
- W2273533722 hasRelatedWork W2355108686 @default.
- W2273533722 hasRelatedWork W2361525666 @default.
- W2273533722 hasRelatedWork W2362773407 @default.
- W2273533722 hasRelatedWork W2363295606 @default.
- W2273533722 hasRelatedWork W2366818149 @default.
- W2273533722 hasRelatedWork W2372942625 @default.
- W2273533722 hasRelatedWork W2375002500 @default.
- W2273533722 hasRelatedWork W2381763375 @default.
- W2273533722 hasRelatedWork W2383731128 @default.
- W2273533722 hasRelatedWork W2383890364 @default.
- W2273533722 hasRelatedWork W2392957904 @default.
- W2273533722 hasRelatedWork W2394139859 @default.
- W2273533722 hasRelatedWork W2410977090 @default.
- W2273533722 hasRelatedWork W2462583081 @default.
- W2273533722 hasRelatedWork W3148036136 @default.
- W2273533722 hasRelatedWork W3159372818 @default.
- W2273533722 hasRelatedWork W3205083309 @default.
- W2273533722 hasVolume "42" @default.
- W2273533722 isParatext "false" @default.
- W2273533722 isRetracted "false" @default.
- W2273533722 magId "2273533722" @default.
- W2273533722 workType "article" @default.